Savant Capital LLC Sells 2,799 Shares of Cardinal Health, Inc. (NYSE:CAH)

Savant Capital LLC cut its holdings in Cardinal Health, Inc. (NYSE:CAH) by 7.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 36,940 shares of the company’s stock after selling 2,799 shares during the period. Savant Capital LLC’s holdings in Cardinal Health were worth $4,369,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in the business. MWA Asset Management boosted its position in Cardinal Health by 2.9% in the 4th quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after buying an additional 95 shares during the period. Paragon Capital Management Inc. boosted its position in Cardinal Health by 0.7% in the 3rd quarter. Paragon Capital Management Inc. now owns 14,857 shares of the company’s stock valued at $1,642,000 after buying an additional 99 shares during the period. Huntington National Bank boosted its position in Cardinal Health by 0.9% in the 3rd quarter. Huntington National Bank now owns 10,792 shares of the company’s stock valued at $1,193,000 after buying an additional 100 shares during the period. Frazier Financial Advisors LLC boosted its position in Cardinal Health by 69.8% in the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock valued at $28,000 after buying an additional 104 shares during the period. Finally, Raleigh Capital Management Inc. boosted its position in Cardinal Health by 29.6% in the 4th quarter. Raleigh Capital Management Inc. now owns 464 shares of the company’s stock valued at $55,000 after buying an additional 106 shares during the period. 87.17% of the stock is currently owned by institutional investors.

Cardinal Health Stock Performance

Shares of NYSE CAH opened at $128.38 on Wednesday. The company’s fifty day moving average price is $122.66 and its 200 day moving average price is $115.83. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $132.84. The company has a market capitalization of $31.01 billion, a PE ratio of 23.95, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH) last announced its quarterly earnings results on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. On average, equities analysts expect that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a dividend of $0.5056 per share. This represents a $2.02 annualized dividend and a yield of 1.58%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s payout ratio is 37.69%.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Bank of America upgraded shares of Cardinal Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. JPMorgan Chase & Co. boosted their price target on shares of Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and boosted their price target for the company from $130.00 to $144.00 in a report on Wednesday, January 8th. Mizuho began coverage on shares of Cardinal Health in a research note on Wednesday, December 4th. They set an “outperform” rating and a $139.00 price objective for the company. Finally, Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective for the company in a research note on Tuesday, January 7th. Four equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $136.87.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.